Heinrichs SC - Search Results

1

Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal.

Heinrichs SC, Lapsansky J, Behan DP, Chan RK, Sawchenko PE, Lorang M, Ling N, Vale WW, De Souza EB. Heinrichs SC, et al. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15475-80. doi: 10.1073/pnas.93.26.15475. Proc Natl Acad Sci U S A. 1996. PMID: 8986836 Free PMC article.

2

Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders.

Behan DP, Grigoriadis DE, Lovenberg T, Chalmers D, Heinrichs S, Liaw C, De Souza EB. Behan DP, et al. Mol Psychiatry. 1996 Sep;1(4):265-77. Mol Psychiatry. 1996. PMID: 9118350 Review.

3

Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors.

Heinrichs SC, Vale EA, Lapsansky J, Behan DP, McClure LV, Ling N, De Souza EB, Schulteis G. Heinrichs SC, et al. Peptides. 1997;18(5):711-6. doi: 10.1016/s0196-9781(97)00120-4. Peptides. 1997. PMID: 9213365

4

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior.

Heinrichs SC, Lapsansky J, Lovenberg TW, De Souza EB, Chalmers DT. Heinrichs SC, et al. Regul Pept. 1997 Jul 23;71(1):15-21. doi: 10.1016/s0167-0115(97)01005-7. Regul Pept. 1997. PMID: 9299637

5

Selective stimulatory actions of corticotropin-releasing factor ligands on correlates of energy balance.

Heinrichs SC, Joppa M, Lapsansky J, Jeske K, Nelson R, De Souza E. Heinrichs SC, et al. Physiol Behav. 2001 Sep 1-15;74(1-2):5-13. doi: 10.1016/s0031-9384(01)00421-8. Physiol Behav. 2001. PMID: 11564446

6

Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease.

Behan DP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, De Souza EB. Behan DP, et al. Among authors: heinrichs sc. Nature. 1995 Nov 16;378(6554):284-7. doi: 10.1038/378284a0. Nature. 1995. PMID: 7477348 Free article.

7

Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist.

Heinrichs SC, De Souza EB, Schulteis G, Lapsansky JL, Grigoriadis DE. Heinrichs SC, et al. Neuropsychopharmacology. 2002 Aug;27(2):194-202. doi: 10.1016/S0893-133X(02)00299-3. Neuropsychopharmacology. 2002. PMID: 12093593

8

Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated.

Heinrichs SC, Min H, Tamraz S, Carmouché M, Boehme SA, Vale WW. Heinrichs SC, et al. Psychoneuroendocrinology. 1997 May;22(4):215-24. doi: 10.1016/s0306-4530(97)00030-9. Psychoneuroendocrinology. 1997. PMID: 9226726

9

Corticotropin-releasing factor receptor blockade enhances conditioned aversive properties of cocaine in rats.

Heinrichs SC, Klaassen A, Koob GF, Schulteis G, Ahmed S, De Souza EB. Heinrichs SC, et al. Psychopharmacology (Berl). 1998 Apr;136(3):247-55. doi: 10.1007/s002130050563. Psychopharmacology (Berl). 1998. PMID: 9566810

10

Selective impairment of corticotropin-releasing factor1 (CRF1) receptor-mediated function using CRF coupled to saporin.

Maciejewski-Lenoir D, Heinrichs SC, Liu XJ, Ling N, Tucker A, Xie Q, Lappi DA, Grigoriadis DE. Maciejewski-Lenoir D, et al. Among authors: heinrichs sc. Endocrinology. 2000 Feb;141(2):498-504. doi: 10.1210/endo.141.2.7336. Endocrinology. 2000. PMID: 10650928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters